Study of KHK2823 in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Clinical trial NCT02181699 · TERMINATED
Trial details
- NCT number
- NCT02181699
- Sponsor
- Kyowa Kirin, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2019-05-10
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.